Sales of Dacogen are already stated in the 10-K. In 2012 the sales of Dacogen:
Eisai had sales of $224.6M
J&J had sales of $55.2M
The first quarter numbers will come in at $20.5M Approx.
Expense are roughly $22.7M
They should report about $2.2M loss or roughly .02 a share loss. Eisai will state earnings around May15, so that's where we could see any future surprises. If J&J can hit sales of dacogen of $100M in sales in 2013, it does trigger a $5M milestone to astex, maybe in the 4Q.
They reported a $1.8M loss before extra ordinary items. Items like Foreign currency loss , hows that happen when they can just pay out of Maxipads bank? I raised an excellent issue with how the currency exchange rates will affect how astex records revenues. Since it wasn't your thought it had to be wrong. I was just glad that maxipad was there to catch you falling jelly. BTW you two dopes, I stated approximate , but somehow both of you have that reading comprehension problem at the same time. What's the odds that both maxi and jelly have the same affliction.